- Home
- RDUS vs JSPRW Comparison
RDUS vs JSPRW Comparison
Compare RDUS & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDUS
- JSPRW
- Stock Information
- Founded
- RDUS 1906
- JSPRW N/A
- Country
- RDUS United States
- JSPRW United States
- Employees
- RDUS N/A
- JSPRW 45
- Industry
- RDUS Industrial Specialties
- JSPRW Biotechnology: Pharmaceutical Preparations
- Sector
- RDUS Consumer Discretionary
- JSPRW Health Care
- Exchange
- RDUS Nasdaq
- JSPRW Nasdaq
- Market Cap
- RDUS N/A
- JSPRW N/A
- IPO Year
- RDUS 1993
- JSPRW 2020
- Fundamental
- Price
- RDUS $12.74
- JSPRW $0.15
- Analyst Decision
- RDUS Hold
- JSPRW
- Analyst Count
- RDUS 2
- JSPRW 0
- Target Price
- RDUS $22.00
- JSPRW N/A
- AVG Volume (30 Days)
- RDUS 335.0K
- JSPRW N/A
- Earning Date
- RDUS 01-07-2025
- JSPRW N/A
- Dividend Yield
- RDUS 5.96%
- JSPRW N/A
- EPS Growth
- RDUS N/A
- JSPRW N/A
- EPS
- RDUS N/A
- JSPRW N/A
- Revenue
- RDUS $2,722,332,000.00
- JSPRW N/A
- Revenue This Year
- RDUS $5.38
- JSPRW N/A
- Revenue Next Year
- RDUS $2.63
- JSPRW N/A
- P/E Ratio
- RDUS N/A
- JSPRW N/A
- Revenue Growth
- RDUS N/A
- JSPRW N/A
- 52 Week Low
- RDUS $10.57
- JSPRW N/A
- 52 Week High
- RDUS $27.70
- JSPRW N/A
- Technical
- Relative Strength Index (RSI)
- RDUS 35.82
- JSPRW N/A
- Support Level
- RDUS $10.76
- JSPRW N/A
- Resistance Level
- RDUS $15.50
- JSPRW N/A
- Average True Range (ATR)
- RDUS 0.80
- JSPRW 0.00
- MACD
- RDUS -0.11
- JSPRW 0.00
- Stochastic Oscillator
- RDUS 38.14
- JSPRW 0.00
About JSPRW Japer Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.